KLC4 Antibodies

Santa Cruz Biotechnology features a diverse variety of KLC4 monoclonal antibodies for investigating kinesin light chain 4 (KLC4) protein function. KLC4 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KLC4 functions as a key component of the kinesin motor protein complex, contributing significantly to intracellular transport processes, particularly in the movement of organelles and vesicles along microtubules. The role of KLC4 is essential for maintaining cellular organization and facilitating communication within cells, making it a crucial focus in cellular dynamics and neurobiology research. Understanding KLC4 mechanisms can provide valuable insights into various diseases, including neurodegenerative disorders. Research focusing on KLC4 has revealed its importance in cellular transport pathways and potential therapeutic applications. Investigating KLC4 continues to uncover new aspects of cellular function and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cellular transport mechanisms and contribute to breakthrough discoveries in cell biology and neuroscience.